ADIPOQ and liver disorder: These results are partially in accordance with results of some recently published studies, which have shown higher levels of adiponectin in CHB patients with advanced liver fibrosis and inflammation [19], [20], although the question of its elevated values in advanced liver disease remains open because adiponectin is an anti-inflammatory factor that contributes to the reduction of inflammation in the liver parenchyma [21].